A synthetic heptapeptide derived from spadin that blocks the TREK-1 potassium channel in the brain. People run it as a nasal spray for mood, low-grade depression, and as a research tool for neurogenesis, often alongside Semax or Selank.
Prices from 2 vendors across the market. We link straight to each vendor’s product page and grade vendors on public lab data, so you’re not just chasing the lowest number.
The simple version first, then a little more for the curious. No biochem degree required.
It blocks a brain potassium channel called TREK-1, which makes serotonin-releasing neurons a little more active. In animal studies that translated into an antidepressant-like effect and new neuron growth.
PE-22-28 is a shortened, more potent analog of spadin, a natural fragment of the sortilin propeptide. It selectively inhibits TREK-1, a two-pore potassium channel. Blocking TREK-1 nudges serotonergic neurons toward firing, which is the same target validated by depression-resistant TREK-1 knockout mice.
TREK-1 sits in mood-related brain regions like the hippocampus and prefrontal cortex. The intranasal route is favored because it can reach the central nervous system through the olfactory and trigeminal nerve pathways, bypassing some of the bloodstream barriers.
In animal models PE-22-28 produced antidepressant-like effects within days and boosted hippocampal neurogenesis over weeks. Human reports are anecdotal and describe a steadier mood floor. Effects, where reported, are described as gradual, not a stimulant hit.
Honest caveat: essentially all of this comes from rodent and lab studies. The original spadin and PE-22-28 work was done in mice, and there are no completed human clinical trials, no validated human dose, and no human safety data. It is not an approved medicine and is sold strictly for research use only. None of this is medical advice, talk to a licensed provider before starting anything.
PE-22-28 is most commonly used as a nasal spray, which puts it close to the brain through the nasal nerves. Some researchers also run it as a subcutaneous injection. The nasal routine is below; lead with it, and note the subcutaneous option if you prefer to inject.
Add bacteriostatic water to the freeze-dried vial down the side, swirl gently, then transfer to a clean nasal-spray bottle. Work out how many micrograms each spray delivers based on your total mg and water volume.
With a fresh bottle, pump a few times into a tissue until a fine mist comes out, so your first real spray is a full, accurate dose.
Tip your head slightly forward, close one nostril, and deliver your measured sprays. A common target is roughly 100–300 mcg total per day, split between nostrils. Sniff gently, do not snort hard.
Switch which nostril you start with each dose to reduce irritation. Keep the bottle refrigerated between uses and out of direct light.
Typical PE-22-28 dose: about 100–300 mcg per day intranasally (or 100–300 mcg subcutaneously), usually once daily in the morning, cycled roughly 4 to 8 weeks on with a 2 to 4 week break. These are scaled-from-animal community numbers, not established therapeutic doses.
How long people run PE-22-28, when to take a break, and the honest reasoning behind it.
Cycled in short blocks, not continuously.
A cycle just means a defined run of time on the peptide, followed by a break. For PE-22-28 the common pattern is roughly 4 to 8 weeks on, then a 2 to 4 week break, rather than running it indefinitely.
Why not just run it forever? Mostly because the long-term human safety data does not exist at all. The cautious and widely followed approach is to run a focused block, then stop and reassess.
Want the full picture, on and off periods, the washout, stacking, and keeping your results? Read how peptide cycling works →
We haven't yet found a vendor publishing a lab certificate for PE-22-28 that we can link to directly. We don't post purity numbers we can't source. When a vendor publishes a real PE-22-28 COA, it'll show up here.
PE-22-28 is a mood-and-cognition peptide, so people pair it with other nasal nootropics rather than the healing stacks. These are the combinations the community reaches for.
Selank takes the edge off anxious overthinking while PE-22-28 is run to lift the serotonergic mood floor. A frequently recommended nasal pairing for people whose main goal is steadier mood.
View stack →Semax is run for drive and focus through dopaminergic and neurotrophic pathways, while PE-22-28 is run for the mood side. The two are seen as complementary rather than competing nasal nootropics.
View stack →A more experimental research pairing. Dihexa is studied for synapse formation while PE-22-28 targets TREK-1 and neurogenesis. Both are early-evidence compounds, so this is firmly a research-only combination.
View stack →Other cognitive and mood peptides people compare against PE-22-28.
PE-22-28 is not an approved drug and is not sold for human use. The vendors we compare offer it strictly for research use only. It falls under WADA's S0 category (non-approved substances), so competing athletes should steer clear. Rules vary by country, so check what applies where you are.
It means the product is sold for laboratory and research purposes, not as a supplement or medicine for people. It has not been reviewed or approved for human use by the FDA, and there are no completed human trials. We aggregate prices and public lab data so you can see the landscape; what you do with that is between you and a licensed provider.
Keep the sealed, freeze-dried vial in the fridge and out of direct light. Once you mix it with bacteriostatic water and transfer it to a spray bottle, keep it refrigerated and use it within a few weeks. Do not freeze a reconstituted bottle.
Both routes are used. Intranasal is the most common because it can reach the brain through the nasal nerves and needs no needle; some researchers prefer subcutaneous injection for more consistent dosing. The compound is the same either way.
In animal studies antidepressant-like effects appeared within a few days, while the neurogenesis effects built over weeks. Human reports are anecdotal and describe gradual changes, not an immediate hit. Treat any timeline as unproven in people.
This site is for educational and informational purposes only and is not medical advice. Nothing here is intended to diagnose, treat, cure, or prevent any disease, and none of these statements have been evaluated by the FDA or any regulatory authority. Talk to a licensed healthcare provider before starting anything.
Peptides and other compounds referenced on this site are sold by third-party vendors strictly as research chemicals for laboratory and research use only. They are not drugs, dietary supplements, cosmetics, or products intended to diagnose, treat, cure, or be consumed by humans or animals, and nothing here is an offer to sell or any encouragement to use them in any such way. You must be at least 18 years old, and of legal age in your jurisdiction, to use this site. Clearly Peptides does not manufacture, sell, supply, or ship any peptides or compounds.
Lab data, grades, and prices are aggregated from publicly available third-party sources, primarily the Janoshik public database and finnrick, plus community-submitted reports. We don't run labs or test anything ourselves. We present this public information, credit each source, and link back to the original report so you can read it yourself. Listing a vendor or compound is not an endorsement.
Clearly Peptides participates in affiliate programs and may earn a commission when you buy through a link or code on this site, at no extra cost to you.
Clearly Peptides is not liable for any actions you take based on the information provided here. Your use of this site is subject to our Terms of Use.